Japan Hospice Holdings Inc. (TYO:7061)
Japan · Delayed Price · Currency is JPY 444.00
+14.00 (3.26%)
Nov 5, 2026, 3:30 PM JST
Japan Hospice Holdings Ratios and Metrics
Market cap in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,766 | 9,438 | 11,441 | 18,197 | 20,770 | 18,405 | |
Market Cap Growth | -67.01% | -17.51% | -37.13% | -12.38% | 12.85% | 36.09% |
Enterprise Value | 14,916 | 20,403 | 22,986 | 26,697 | 27,494 | 23,306 |
Last Close Price | 444.00 | 1120.00 | 1358.15 | 2188.09 | 2497.36 | 2231.58 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.39 | 33.95 | 17.90 | 26.72 | 45.75 | 76.69 |
Forward PE | - | 13.02 | 11.30 | 24.43 | 32.88 | 48.24 |
PS Ratio | 0.25 | 0.67 | 0.94 | 1.84 | 2.63 | 3.06 |
PB Ratio | 1.03 | 2.57 | 3.32 | 6.76 | 10.20 | 11.99 |
P/TBV Ratio | 1.14 | 2.87 | 3.74 | 8.08 | 13.67 | 17.14 |
P/FCF Ratio | - | - | - | - | 59.34 | - |
P/OCF Ratio | 3.03 | 9.02 | 13.70 | 16.10 | 23.79 | 39.41 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.99 | 1.44 | 1.90 | 2.71 | 3.48 | 3.87 |
EV/EBITDA Ratio | 8.73 | 14.25 | 12.64 | 15.76 | 21.23 | 28.25 |
EV/EBIT Ratio | 13.58 | 24.03 | 17.86 | 20.81 | 28.64 | 38.97 |
EV/FCF Ratio | - | - | - | - | 78.55 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 3.57 | 3.59 | 3.83 | 4.05 | 3.97 | 4.35 |
Debt / EBITDA Ratio | 7.65 | 9.21 | 7.25 | 6.43 | 6.25 | 8.09 |
Debt / FCF Ratio | - | - | - | - | 23.11 | - |
Net Debt / Equity Ratio | 3.05 | 3.04 | 3.39 | 3.35 | 3.23 | 3.67 |
Net Debt / EBITDA Ratio | 6.52 | 7.80 | 6.41 | 5.32 | 5.08 | 6.83 |
Net Debt / FCF Ratio | -54.39 | -8.45 | -5.19 | -10.57 | 18.80 | -3.91 |
Asset Turnover | 0.82 | 0.76 | 0.72 | 0.74 | 0.77 | 0.78 |
Quick Ratio | 1.32 | 1.26 | 1.16 | 1.85 | 1.70 | 1.01 |
Current Ratio | 1.39 | 1.34 | 1.27 | 1.91 | 1.75 | 1.06 |
Return on Equity (ROE) | 9.20% | 7.81% | 20.82% | 28.81% | 26.77% | 17.19% |
Return on Assets (ROA) | 3.74% | 2.85% | 4.81% | 6.03% | 5.83% | 4.84% |
Return on Invested Capital (ROIC) | 3.87% | 2.84% | 6.09% | 8.38% | 7.42% | 5.83% |
Return on Capital Employed (ROCE) | 7.00% | 5.50% | 8.40% | 9.70% | 9.80% | 8.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.78% | 2.95% | 5.58% | 3.74% | 2.19% | 1.30% |
FCF Yield | -5.44% | -14.01% | -19.65% | -4.68% | 1.69% | -7.82% |
Dividend Yield | 5.63% | 2.23% | 1.08% | - | - | - |
Payout Ratio | 63.64% | 44.25% | - | - | - | - |
Buyback Yield / Dilution | -0.45% | -0.70% | -3.73% | -0.14% | -0.47% | 0.03% |
Total Shareholder Return | 5.18% | 1.53% | -2.65% | -0.14% | -0.47% | 0.03% |